Hemagglutinin \[heʹmə-glooʹtĭ-nin\] and neuraminidase \[noorʹə-minʹĭ-dās\]
==========================================================================

In 1941, virologist George K. Hirst discovered that adding influenza virus to red blood cells (erythrocytes) in a test tube caused the cells to agglutinate, mediated by one of the virus surface glycoproteins, hemagglutinin (from the Greek *haima*, "blood," + Latin *gluten*, "glue") ([Figure](#F1){ref-type="fig"}). Alfred Gottschalk later showed that hemagglutinin binds virus to host cells by attaching to sialic acids (from the Greek *sialon*, "saliva") on carbohydrate side chains of cell-surface glycoproteins and glycolipids. The other influenza virus surface protein, neuraminidase (referring to brain lipids from which it was first derived) is a virus receptor-destroying enzyme that removes its substrate, sialic acids, from infected cell surfaces so that newly made progeny viruses are released to infect additional cells. At present, 18 hemagglutinin subtypes (H1--H18) and 11 neuraminidase subtypes (N1--N11) are recognized.
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